Company intelligence / Profile preview
Changchun Tuohua Pharmaceutical
- Ownership
- Private
- Development stage
- Other
Overview
Changchun Tuohua Pharmaceutical is a Chinese biopharmaceutical company specializing in the research, development, and manufacturing of recombinant protein therapeutics. Based in Changchun, Jilin Province, the company is a recognized player in the domestic production of cytokines and interferons. Its primary commercial portfolio includes Recombinant Human Interleukin-2 and Recombinant Human Interferon α2b, which are utilized in the treatment of various malignancies and viral infections. The company operates GMP-certified facilities and focuses on providing biological solutions for oncology and infectious disease management within the Chinese healthcare market.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Recombinant proteinCytokine
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Changchun Tuohua Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Changchun Tuohua Pharmaceutical.